SATB2 (SATB homeobox 2) is an AT rich DNA-binding protein. It is a homologue of SATB1 protein. This gene is localized to human chromosome 2q33.1, and is highly conserved across different species.
Synonyms: SATB2 Antibody - Anti-SATB2 antibody produced in rabbit; Satb2 Antibody; Anti-APXL3; Anti-FLJ21474; Anti-KIAA1034; Anti-KIAA1481; Anti-SATB homeobox 2; Anti-SHRM; Anti-ShrmL
Storage: -20C
Application: Anti-SATB2 antibody produced in rabbit, a Prestige Antibody, is developed and validated by the Human Protein Atlas (HPA) project (www.proteinatlas.org). Each antibody is tested by immunohistochemistry against hundreds of normal and disease tissues. These images can be viewed on the Human Protein Atlas (HPA) site by clicking on the Image Gallery link. The antibodies are also tested using immunofluorescence and western blotting. To view these protocols and other useful information about Prestige Antibodies and the HPA, visit sigma.com/prestige.
Biochem Physiol Actions: Special AT-rich sequence-binding protein 2 (SATB2) binds to nuclear matrix-attachment regions (MAR), displays functional versatility in central nervous development, especially corpus callosum and pons formation, cancer development and prognosis, as well as in immune regulation. The gene is a nuclear matrix-associated transcription factor and epigenetic regulator that is involved in osteoblastic differentiation. It is expressed in the glandular epithelial cells of the lower gastrointestinal tract. It plays a critical role in osteoblast lineage commitment and might be involved in the development and progression of laryngeal squamous cell carcinoma (LSCC) as a tumor suppressor. SATB2 is a marker of osteoblastic differentiation in benign and malignant mesenchymal tumours and colorectal adenocarcinomas.
Legal Information: Prestige Antibodies is a registered trademark of Sigma-Aldrich Co. LLC